Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon
- PMID: 6782927
- DOI: 10.7326/0003-4819-94-4-482
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon
Abstract
Von Willebrand factor activity and factor VIII/von Willebrand factor (fVIII/vWf) antigen concentrations were evaluated in 17 patients with scleroderma, nine patients with Raynaud's phenomenon, and eight control volunteers. Higher circulating levels of both activities were seen: von Willebrand factor, 374% +/- 40% (percent of control values) in scleroderma patients, 502% +/- 104% in patients with Raynaud's phenomenon and 102% +/- 6% in control subjects (p less than 0.005, scleroderma versus control): fVIII/vWf antigen, 255% +/- 24% in scleroderma patients; 271% +/- 46% in patients with Raynaud's phenomenon, and 99% +/- 4% in control subjects (p less than 0.005, scleroderma versus control). Because endothelial cells synthesize and secrete both substances, the role of endothelial injury in vitro was investigated. Wound injury induced a 344% +/- 33% increase in von Willebrand factor and a 115% +/- 5% increases in fVIII/vWf antigen; cold injury induced 644% +/- 66% and 150% +/- 10% increases, and cytotoxic endothelial injury induced 1055% +/- 83% and 185% +/- 20% increases. In five patients with scleroderma, cold exposure led to a further increase in both activities. The observed increase of both activities in scleroderma and Raynaud's phenomenon may reflect in-vivo endothelial injury and regeneration in these related conditions.
Similar articles
-
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.Ann Rheum Dis. 1996 Feb;55(2):122-7. doi: 10.1136/ard.55.2.122. Ann Rheum Dis. 1996. PMID: 8712862 Free PMC article.
-
Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.Br J Rheumatol. 1991 Dec;30(6):433-6. doi: 10.1093/rheumatology/30.6.433. Br J Rheumatol. 1991. PMID: 1747698
-
Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.Acta Haematol. 1992;88(4):189-93. doi: 10.1159/000204684. Acta Haematol. 1992. PMID: 1337960
-
Interaction between VWF and FVIII in treating VWD.Eur J Haematol. 2015 Nov;95(5):449-54. doi: 10.1111/ejh.12514. Epub 2015 Feb 19. Eur J Haematol. 2015. PMID: 25605439 Review.
-
[Factor VIII/von Willebrand factor complex (FVIII/vWF)].Rinsho Byori. 1985 Feb;Spec No 61:73-85. Rinsho Byori. 1985. PMID: 3923232 Review. Japanese. No abstract available.
Cited by
-
Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.J Clin Invest. 1990 Aug;86(2):474-80. doi: 10.1172/JCI114733. J Clin Invest. 1990. PMID: 2384595 Free PMC article.
-
An investigation into the acute vascular effects of riveting.Br J Ind Med. 1993 Feb;50(2):160-6. doi: 10.1136/oem.50.2.160. Br J Ind Med. 1993. PMID: 8435349 Free PMC article.
-
In vitro cytotoxicity of human endothelial cells in polymyalgia rheumatica and giant cell arteritis.Rheumatol Int. 1982;2(3):133-6. doi: 10.1007/BF00541166. Rheumatol Int. 1982. PMID: 7163734
-
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.Ann Rheum Dis. 1996 Feb;55(2):122-7. doi: 10.1136/ard.55.2.122. Ann Rheum Dis. 1996. PMID: 8712862 Free PMC article.
-
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.N Engl J Med. 2014 Jan 30;370(5):433-43. doi: 10.1056/NEJMoa1114576. Epub 2013 Dec 18. N Engl J Med. 2014. PMID: 24350901 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous